Список использованных источников
1 Kiess M., Scharm B., Aguzzi A., Hajnal A., Klemenz R., Schwarte-Waldhoff I., Schafer R. Expression of ril, a novel LIM domain gene, is down-regulated in Hras-transformed cells and restored in phenotypic revertants.// Oncogene. - 1995. -V. 10. -P. 61-68.
2 Bashirova A.A., Markelov M.L., Shlykova T.V., Levshenkova E.V., Alibaeva R.A., Frolova E.I. The human RIL gene: mapping to human chromosome 5q31.1, genomic organization and alternative transcripts.// Gene. - 1998. -V. 210. -P. 239-245.
3 Vallenius T., Scharm B., Vesikansa A., Luukko K., Schafer R., Makela T.P. The PDZ-LIM protein RIL modulates actin stress fiber turnover and enhances the association of alpha-actinin with F-actin.// Exp Cell Res. - 2004. -V. 293. -P. 117-128.
4 Jani K.,Schock F. Zasp is required for the assembly of functional integrin adhesion sites.// J Cell Biol. - 2007. -V. 179. -P. 1583-1597.
5 McKeown C.R., Han H.F., Beckerle M.C. Molecular characterization of the Caenorhabditis elegans ALP/Enigma gene alp-1.// Dev Dyn. - 2006. -V. 235. -P. 530-538.
6 Te Velthuis A.J., Isogai T., Gerrits L., Bagowski C.P. Insights into the molecular evolution of the PDZ/LIM family and identification of a novel conserved protein motif.// PLoS One. - 2007. -V. 2. -P. e189.
7 Krcmery J., Camarata T., Kulisz A., Simon H.G. Nucleocytoplasmic functions of the PDZ-LIM protein family: new insights into organ development.// Bioessays. - 2010. -V. 32. -P. 100-108.
8 Schulz T.W., Nakagawa T., Licznerski P., Pawlak V., Kolleker A., Rozov A., Kim J., Dittgen T., Kohr G., Sheng M., Seeburg P.H., Osten P. Actin/alpha-actinin-dependent transport of AMPA receptors in dendritic spines: role of the PDZ-LIM protein RIL.// J Neurosci. - 2004. -V. 24. -P. 8584-8594.
9 Vallenius T., Luukko K., Makela T.P. CLP-36 PDZ-LIM protein associates with nonmuscle alpha-actinin-1 and alpha-actinin-4.// J Biol Chem. - 2000. -V. 275. -P. 11100-11105.
10 Klaavuniemi T., Kelloniemi A., Ylanne J. The ZASP-like motif in actinin-associated LIM protein is required for interaction with the alpha-actinin rod and for targeting to the muscle Z-line.// J Biol Chem. - 2004. -V. 279. -P. 26402-26410.
11 Zheng M., Cheng H., Banerjee I., Chen J. ALP/Enigma PDZ-LIM domain proteins in the heart.// J Mol Cell Biol. - 2010. -V. 2. -P. 96-102.
12 Benna C., Peron S., Rizzo G., Faulkner G., Megighian A., Perini G., Tognon G., Valle G., Reggiani C., Costa R., Zordan M.A. Post-transcriptional silencing of the Drosophila homolog of human ZASP: a molecular and functional analysis.// Cell Tissue Res. - 2009. -V. 337. -P. 463-476.
13 van der Meer D.L., Marques I.J., Leito J.T., Besser J., Bakkers J., Schoonheere E., Bagowski C.P. Zebrafish cypher is important for somite formation and heart development.// Dev Biol. - 2006. -V. 299. -P. 356-372.
14 Pashmforoush M., Pomies P., Peterson K.L., Kubalak S., Ross J., Jr., Hefti A., Aebi U., Beckerle M.C., Chien K.R. Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy.// Nat Med. - 2001. -V. 7. -P. 591-597.
15 Zhou Q., Chu P.H., Huang C., Cheng C.F., Martone M.E., Knoll G., Shelton G.D., Evans S., Chen J. Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy.// J Cell Biol. - 2001. -V. 155. -P. 605-612.
16 Vatta M., Mohapatra B., Jimenez S., Sanchez X., Faulkner G., Perles Z., Sinagra G., Lin J.H., Vu T.M., Zhou Q., Bowles K.R., Di Lenarda A., Schimmenti L., Fox M., Chrisco M.A., Murphy R.T., McKenna W., Elliott P., Bowles N.E., Chen J., Valle G., Towbin J.A. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction.// J Am Coll Cardiol. - 2003. -V. 42. -P. 2014-2027.
17 Selcen D.,Engel A.G. Mutations in ZASP define a novel form of muscular dystrophy in humans.// Ann Neurol. - 2005. -V. 57. -P. 269-276.
18 Xing Y., Ichida F., Matsuoka T., Isobe T., Ikemoto Y., Higaki T., Tsuji T., Haneda N., Kuwabara A., Chen R., Futatani T., Tsubata S., Watanabe S., Watanabe K., Hirono K., Uese K., Miyawaki T., Bowles K.R., Bowles N.E., Towbin J.A. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity.// Mol Genet Metab. - 2006. -V. 88. -P. 71-77.
19 Guryanova O.A., Drazba J.A., Frolova E.I., Chumakov P.M. Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.// J Biol Chem. - 2011. -V. 286. -P. 26849-26859.
20 Zhang Y., Tu Y., Zhao J., Chen K., Wu C. Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle.// J Cell Biol. - 2009. -V. 184. -P. 785-792.
21 Xu J., Shetty P.B., Feng W., Chenault C., Bast R.C., Jr., Issa J.P., Hilsenbeck S.G., Yu Y. Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome.// BMC Cancer. - 2012. -V. 12. -P. 1471-2407.
22 Feng W., Orlandi R., Zhao N., Carcangiu M.L., Tagliabue E., Xu J., Bast R.C., Jr., Yu Y. Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers.// BMC Cancer. - 2010. -V. 10. -P. 378.
23 Boumber Y.A., Kondo Y., Chen X., Shen L., Gharibyan V., Konishi K., Estey E., Kantarjian H., Garcia-Manero G., Issa J.P. RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis.// Cancer Res. - 2007. -V. 67. -P. 1997-2005.
24 Vanaja D.K., Ballman K.V., Morlan B.W., Cheville J.C., Neumann R.M., Lieber M.M., Tindall D.J., Young C.Y. PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer.// Clin Cancer Res. - 2006. -V. 12. -P. 1128-1136.
25 Wei D., Sun N., Nan G., Wang Y., Liu H.Q., Peeters B., Chen Z.N., Bian H. Construction of Recombinant Newcastle Disease Virus Italien Strain for Oncolytic Virotherapy of Tumors.// Hum Gene Ther. - 2012. -V. 28. -P. 28.
26 Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.// Molecular biology and evolution. - 2007. -V. 24. -P. 1596-1599.
27 Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.// Journal of molecular evolution. - 1980. -V. 16. -P. 111-120.
28 Rozas J., Sanchez-DelBarrio J.C., Messeguer X., Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods.// Bioinformatics. - 2003. -V. 19. -P. 2496-2497.
29 Nei M.,Miller J.C. A simple method for estimating average number of nucleotide substitutions within and between populations from restriction data.// Genetics. - 1990. -V. 125. -P. 873-879.
30 Sugiura N. Further analysis of the data by Akaike's information criterion and the finite corrections.// Commun. Stat. Theory Meth. - 1978. -V. A7. -P. 13–26.
31 Pond S.L.,Frost S.D. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments.// Bioinformatics. - 2005. -V. 21. -P. 2531-2533.
1. Flynn D.C. 2001. Adaptor proteins. Oncogene. 20, 6270-6272.
2. Kadrmas J.L., Beckerle M.C. 2004. The LIM domain: from the cytoskeleton to the nucleus. Nat. Rev. Mol. Cell Biol. 5, 920-931. 3. Dawid I.B., Breen J.J., Toyama R. 1998. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet. 14, 156-162. 4. Wang Y., Gilmore T.D. 2001. LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. Biochim. Biophys. Acta. 1538, 260-272.
5. Tanaka T., Soriano M.A., Grusby M.J. 2005. SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity. 22, 729-736.
6. Ungureanu D., Silvennoinen O. 2005. SLIM trims STATs: Ubiquitin E3 ligases provide insights in the regulation of cytokine signaling. Science’s STKE, 304, pe49.
7. Capilli A.D., Schultz D.C., Rauscher III F.J., Borden K.L. 2001. Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO J. 20, 165-177.
8. Pawson T., Nash P. 2003. Assembly of cell regulatory systems through protein interaction domains. Science. 300, 445-452.
9. Fanning A.S., Anderson J.M. 1999. PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J. Clin. Invest. 103, 767-772.
10. Pallen M.J., Ponting C.P. 1997. PDZ domains in bacterial proteins. Mol. Microbiol. 26, 411-413.
11. Ponting C.P. 1997. Evidence for PDZ domains in bacteria, yeast, and plants. Protein Sci. 6, 464-468.
12. Harris B.Z., Lim W.A. 2001. Mechanism and role of PDZ domains in signaling complex assembly. J. Cell Sci. 114, 3219-3231.
13. Muhlhahn P., Zweckstetter M., Georgescu J., Ciosto C., Renner C., Lanzendorfer M., Lang K., Ambrosius D., Baier M., Kurth R., Holak T.A. 1998. Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site. Nat. Struct. Biol. 5, 682-686.
14. Fan J.-S., Zhang M. 2002. Signaling complex organization by PDZ domain proteins. Neurosignals. 11, 315-321.
15. Hung A.Y., Sheng M. 2002. PDZ domains: structural modules for protein complex assembly. J. Biol. Chem. 277, 5699-5702.
16. Besprozvanny I., Maximov A. 2001. Classification of PDZ domains. FEBS Lett. 509, 457-462.
17. Songyang Z., Fanning A.S., Fu C., Xu J., Marfatia S.M., Chishti A.H., Crompton A., Chan A.C., Anderson J.M., Cantley L.C. 1997. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science (Washington D.C.) 275, 73-77.
18. Van den Berk L.C.J., van Ham M.A., te Lindert M.M., Walma T., Aelen J., Vuister G.W., Hendriks W.J.A.J. 2004. The interaction of PTP-BL PDZ domains with RIL: an enigmatic role for the RIL LIM domain. Mol. Biol. Rep. 31, 203-215.
19. Ponting C.P., Phillips C., Davies K.E., Blake D.J. 1997. PDZ domains: targeting signaling molecules to sub-membranous sites. Bioessays. 19, 469-479.
20. Nourry C., Grant S.G.N., Borg J.-P. 2003. PDZ Domain Proteins: Plug and Play! Science’s STKE. re7.
21. Jelen F., Oleksy A., Smietana K., Otlewski J. 2003. PDZ domains – common players in the cell signaling. Acta Biochim. Pol. 50, 985-1017.
22. Yi J., Beckerle M.C. 1998. The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis. Genomics. 49, 314-316. 23. Murthy K.K., Clark K., Fortin Y., Shen S.-H., Banville D. 1999. ZRP-1, a zyxin related protein, interacts with the second PDZ domain of the cytosolic protein tyrosine phosphatase hPTP1E. J. Biol. Chem. 274, 20679-20687.
24. Wang Y., Gilmore T.D. 2001. LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. Biochim. Biophys. Acta. 1538, 260-272.
25. Yi J., Kloeker S., Jensen C.C., Bockholt S., Honda H., Hirai H., Beckerle M.C. 2002. Members of the zyxin family of LIM proteins interact with members of the p130Cas family of signal transducers. J. Biol. Chem. 277, 9580-9589.
26. Sanz-Rodriguez F., Guerrero-Esteo M., Botella L.-M., Banville D, Vary C.P.H., Bernabéu C. 2004. Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the LIM family of proteins. J. Biol. Chem. 279, 32858-32868.
27. Lai Y.-J., Chen C.-S., Lin W.-C., Lin F.-T. 2005. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration. Mol. Cell. Biol. 25, 5859-5868.
28. Lee J.W., Choi H.-S., Gyuris J.,Brent R., Moore D.D. 1995. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Endocrinology. 9, 243-254. 29. Kassel O., Schneider S., Heilbock C., Litfin M., Göttlicher M., Herrlich P. 2004. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-κB-regulated promoters. Genes Dev. 18, 2518-2528. 30. Li L., Bin L.H., Liu Y., Chen D., Zhai Z., Shu H.B. 2005. TRIP6 is RIP2-associated common signaling component of multiple NF-κB activation pathways. J. Cell Sci. 118, 555-563.
31. Kiess M., Scharm B., Aguzzi A., Hajnal A., Klemez R., Schwarte-Waldhoff I., Schäfer R. 1995. Expression of ril, a novel LIM domain gene, is down-regulated in HRAS-transformed cells and restored in phenotypic revertants. Oncogene. 10, 61-68.
32. Cuppen E., Gerrits H., Pepers B., Wieringa B., Hendriks W. 1998. PDZ motifs in PTP-BL and RIL bind to internal protein segments in the LIM domain protein RIL. Mol. Biol. Cell. 9, 671-683.
33. Xia H., Winokur S.T., Kuo W.L., Altherr M.R., Bredt D.S. 1997. Actinin-associated LIM protein: identification of a domain interaction between PDZ and spectrin-like repeat. J. Cell Biol. 139, 507-515.
34. Wang H., Harrison-Shostak D.C., Lemasters J.J., Herman B. 1995. Cloning of a rat cDNA encoding a novel LIM domain protein with high homology to rat RIL. Gene. 165, 267-71.
35. Kotaka M., Ngai S.M., Garcia-Barcelo M., Tsui S.K., Fung K.P., Lee C.Y., Waye M.M. 1999. Characterization of the human 36-kDa carboxyl terminal LIM domain protein (hCLIM1). J. Cell Biochem. 72, 279-285.
36. Bashirova A.A., Markelov M.L., Shlykova T.V., Levshenkova E.V., Alibaeva R.A., Frolova E.I. 1998. The human RIL gene: mapping to human chromosome 5q31.1, genomic organization and alternative transcripts. Gene. 210, 239-245.
|
